This approach enabled us to identify distinctive spatial Aβ, tau, and Aβ∙tau neuronal activity alteration patterns via statistical evaluation of the neuronal excitability perturbations in the AD vs. CU groups. This evidence concerns the gene MAPT and Alzheimer disease.